• 1. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

Recent Advances in the Study of 2-(4-Chlorophenyl)Imidazo1,2-APyridine-3-Carbaldehyde (CAS: 478257-35-1)

2-(4-Chlorophenyl)Imidazo1,2-APyridine-3-Carbaldehyde (CAS: 478257-35-1) is a chemical compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This compound, characterized by its imidazo[1,2-a]pyridine core, has been the subject of numerous studies aimed at exploring its pharmacological properties and synthetic utility. The following sections provide an overview of the latest research findings related to this compound, including its synthesis, biological activities, and potential therapeutic applications.

Recent studies have focused on optimizing the synthetic pathways for 2-(4-Chlorophenyl)Imidazo1,2-APyridine-3-Carbaldehyde. A 2023 publication in the Journal of Medicinal Chemistry reported a novel one-pot synthesis method that significantly improves yield and purity compared to traditional approaches. The method utilizes a palladium-catalyzed coupling reaction, followed by an oxidative cyclization step, to achieve the desired product with high efficiency. This advancement is particularly noteworthy as it addresses previous challenges related to scalability and cost-effectiveness in large-scale production.

In terms of biological activity, 2-(4-Chlorophenyl)Imidazo1,2-APyridine-3-Carbaldehyde has demonstrated promising results as a modulator of various enzymatic pathways. A study published in Bioorganic & Medicinal Chemistry Letters in 2024 highlighted its inhibitory effects on protein kinases involved in inflammatory responses. The compound exhibited nanomolar potency against specific kinase targets, suggesting its potential as a lead compound for the development of anti-inflammatory therapeutics. Additionally, molecular docking studies revealed favorable binding interactions with the active sites of these kinases, further supporting its pharmacological relevance.

Another area of interest is the compound's potential application in oncology. Preliminary in vitro studies conducted in 2023 showed that 2-(4-Chlorophenyl)Imidazo1,2-APyridine-3-Carbaldehyde induces apoptosis in certain cancer cell lines, particularly those associated with solid tumors. Mechanistic investigations indicated that the compound triggers mitochondrial dysfunction and activates caspase-dependent apoptotic pathways. These findings have spurred further research into its use as a chemotherapeutic agent, with ongoing preclinical trials aiming to evaluate its efficacy and safety profiles in animal models.

Despite these promising developments, challenges remain in the clinical translation of 2-(4-Chlorophenyl)Imidazo1,2-APyridine-3-Carbaldehyde. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through systematic structure-activity relationship (SAR) studies. Recent efforts have focused on derivatizing the core structure to enhance its pharmacokinetic properties while retaining its biological activity. A 2024 review in Current Topics in Medicinal Chemistry summarized these efforts, emphasizing the need for multidisciplinary approaches to overcome these hurdles.

In conclusion, 2-(4-Chlorophenyl)Imidazo1,2-APyridine-3-Carbaldehyde (CAS: 478257-35-1) represents a versatile scaffold with significant potential in drug discovery. Recent advancements in its synthesis and biological evaluation have laid a strong foundation for future research. However, further studies are required to fully exploit its therapeutic potential and address existing limitations. The compound's unique chemical structure and diverse biological activities make it a compelling candidate for continued investigation in the fields of medicinal chemistry and pharmacology.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)